drugset / Trial / NCT07668934
TAF in Early/Middle Pregnancy With CHB
Phase 4
Enrolling by invitation
816 enrolled
The Third Affiliated Hospital of Guangzhou Medical University
Qingyuan People's Hospital · collabSecond Affiliated Hospital of Guangzhou Medical University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to study the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy with chronic hepatitis B.
Timeline
- Start
- 2025-03-31
- Primary completion
- 2027-03-30
- Completion
- 2028-03-30